Advertisement
Advertisement

TELO

TELO logo

Telomir Pharmaceuticals, Inc. Common Stock

1.30
USD
Sponsored
-0.02
-1.52%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

1.34

+0.04
+3.38%

Telomir Pharmaceuticals, Inc. Common Stock Profile

About

Telomir Pharmaceuticals Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Telomir Pharmaceuticals Inc. is based in BALTIMORE.

Info & Links

CEO

Erez Aminov

Headquarters

100 SE 2ND STREET, SUITE 2000 -1009
MIAMI, FL 33131, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.telomirpharma.com

Auditor

Cherry Bekaert LLP

Share holders

58

Employees

2

Telomir Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

92.43M

Enterprise Value

85.14M

Enterprise Value/EBITDA(ttm)

-8.08

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

7.33

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-315.26%

Return on Invested Capital(ttm)

248.85%

Return on Assets(ttm)

-259.29%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-10.54M

Net Income Available to Common(ttm)

-10.41M

Diluted EPS(ttm)

-0.33

Share Statistics

Beta (5Y Monthly)

-0.73

52-Week Change

-48.41%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

34.38M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

7.29M

Total Cash Per Share(mrq)

0.21

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.14%

Quick Ratio(mrq)

5.14%

Book Value Per Share(mrq)

0.17

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.12

Free Cash Flow(ytd)

-3.69M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement